Across TCGA pan-cancer cohorts, RPS20P13 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RPS20P13’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RPS20P13 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS20P13 is over-expressed in tumor, although a few such as READ show the opposite, repressed pattern.

KIRC, READ, and PRAD are the cancer types where RPS20P13 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS20P13 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.096	<.001	6	view →
READ	All	All	−0.648	.006	2	view →
PRAD	All	All	+0.370	<.001	2	view →
HNSC	All	IV	+0.060	.014	2	view →
KIRP	Male	All	+0.028	.037	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: RPS20P13 RNA expression & survival · all RPS20P13 data types